CD4 and nasopharyngeal carcinoma: To assess immune cells that expressed these biomarkers, we next investigated the expression patterns of CD4, CD27, CD11c/ITGAX, IDO1, and Fibronectin/FN1 across cell types by using publicly accessible single-cell mRNA datasets from NPC samples (Figure S7) [13,26].